Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura
Clinical trial NCT05876221 · COMPLETED
Trial details
- NCT number
- NCT05876221
- Sponsor
- University of Cologne
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-30
- Primary completion
- 2025-03-30
- Enrollment
- 223
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.